Immunomodulating drugs

Glutathione S-transferase P (EC 2.5.

Glutathione S-transferase theta-1 (EC 2.5.

Immunogen glutathione S-transferase theta 2B (gene/pseudogene) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen Synthetic peptide directed towards the N terminal region of human GSTZ1 Application Anti-GSTZ1 antibody produced in rabbit is suitable for western blotting at a concentration of 2.5&#956g/ml.

Immunogen Maleylacetoacetate isomerase recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are

The enzyme consists of &#945 and &#946 subunits of ~80kDa and ~70kDa respectively. Both the units are required for catalytic activity.

Soluble guanylyl cyclase (sGC) is an obligate hemoprotein enzyme consisting of &#945 and &#946 subunits of ~80 kDa and ~70 kDa, respectively. Immunogen synthetic peptide corresponding to amino acid residues 189-207, with N-terminal added lysine,

GUCD1 (Guanylyl cyclase domain containing 1) is a highly conserved ubiquitous protein with abundant expression in different tissues. Its upregulated expression have been found in liver tissues during early liver regeneration.

The gene GUCY1B3 (guanylate cyclase soluble subunit &#946-1) is mapped to human chromosome 4q31.3-q33.

The guanylate cyclase 2C (GUCY2C) gene, mapped to human chromosome 12p12, codes for the transmembrane receptor guanylate cyclase C (GC-C). The encoded protein is expressed in intestine.

Immunogen guanylate kinase 1 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by

Immunogen guanylate kinase 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.